Delivery Order SPE2DB20D2200-SPE2DB23FX00N
Award Date 9/8/23
Potential Completion Date 9/11/23
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,223.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of ACTEMRA. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by June 27, 2023 under the terms set forth in the contract. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime without...
- The Defense Logistics Agency awarded a $5,511.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of ACTEMRA. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product to a location in Conshohocken, Pennsylvania by August 3, 2023 under the terms of the order. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime without involvement of...
- The Defense Logistics Agency awarded a $9,044.53 delivery order to Amerisourcebergen Drug Corporation for 4561917775 units of ACTEMRA 162 MG/0.9 ML SYRINGES. The contract has a firm fixed price and place of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The delivery order is associated with DLA's pharmaceutical procurement programs and supports the medical readiness of the Department of Defense. No...
- The Defense Logistics Agency Troop Support Medical awarded a $2,599 firm fixed price delivery order to Amerisourcebergen Drug Corp for 162 mg/0.9 ml syringes of Actemra. Performance will take place in Conshohocken, Pennsylvania over July 5-6, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, the prime contractor. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring pharmaceuticals and other...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $17,028 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561317671 units of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML to be delivered from the prime contractor's place of performance in Conshohocken, Pennsylvania between June 22nd and 23rd, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp Corporate Office Division, the prime...
- The Defense Logistics Agency awarded a $1,299.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml doses of ACTEMRA ACTPEN tocilizumab injection prefilled syringe. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the product to a location in Conshohocken, Pennsylvania between August 10-11, 2023. The award is associated with DLA's prime vendor program, through which it obtains pharmaceuticals and other medical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $11,913.90 to Amerisourcebergen Drug Corporation for ACTEMRA 162 MG/0.9 ML SYRINGES. The place of performance will be in Conshohocken, Pennsylvania from August 17-18, 2023. Amerisourcebergen Corporation will serve as the prime contractor to supply pharmaceutical products to the Defense Logistics Agency, which supports Department of Defense health care requirements. No subcontractors or set...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical Center. The $10,494.03 order is to supply 162 milligrams per 0.9 milliliter syringes of Actemra for delivery by February 8, 2022. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency Troop Support Medical awarded a $5,198.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 26-27, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply the prescription medication Actemra, used to treat rheumatoid...
- The Defense Logistics Agency awarded a $12,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will deliver 4561904907 ACTEMRA ACTPEN 162 MG/0.9 ML prefilled syringes to a location in Conshohocken, Pennsylvania by August 23, 2023 in support of DLA's medical supply needs. As a top 50 Defense Department contractor, Amerisourcebergen has extensive experience providing pharmaceuticals and medical supplies under...
- SPE2DB20D2200Indefinite Delivery Contract
- SPE2DB20D2200-SPE2DB23FX00NDelivery Order
The Defense Logistics Agency awarded a $2,637.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of ACTEMRA to be delivered by September 11, 2023. The delivery location is Amerisourcebergen's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were indicated. This order is likely associated with the DLA's stockpile of pharmaceuticals and medical supplies to support the Department of Defense's healthcare programs and military treatment facilities.
Generated 12/15/23, 11:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/8/23 |